Text Size

Catalyst Researcher David Calkins Receives Senior Scientific Investigator Award

David Calkins, PhD, Vice Chair and Director of Research for the Vanderbilt Eye Institute, was recently awarded a Research to Prevent Blindness Senior Scientific Investigator Award.

The $150,000 award will assist Dr. Calkins in his efforts to develop new studies of self-repair mechanisms in diseases that impact the central nervous system.

"This award was given to help me develop a new line of investigation that focuses on how neural pathways fight back against central nervous system diseases like Alzheimer’s and glaucoma," said Calkins, the Denis M. O’Day Professor of Ophthalmology of Visual Sciences.

"We have discovered a certain level of plasticity that occurs in the adult nervous system during disease progression to conserve signaling as long as possible."

Glaucoma is the most common blinding eye disease in the world. By 2020, the National Eye Institute projects that about 80 million people will be diagnosed with glaucoma.

Dr. Calkins is one of 184 scientists to receive the Senior Scientific Investigator Award since 1987. He is a founding principal investigator in the Catalyst for a Cure consortium funded by the Glaucoma Research Foundation.

Last reviewed on October 29, 2017

Was this helpful? Yes No